Latest debt-to-equity ratio
Krystal Biotech Debt-to-equity ratio
Direct answer
Krystal Biotech's debt-to-equity ratio is 0.65%.
The verified market snapshot reports 0.65%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 11, 2026.
Get free Krystal Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.65%
Explore related company data
View Krystal Biotech's market capitalizationView Krystal Biotech's p/e ratioView Krystal Biotech's price-to-book ratioView Krystal Biotech's return on equityView Krystal Biotech's dividend yieldView Krystal Biotech's 52-week price rangeView Krystal Biotech's revenue growthView Krystal Biotech's profit marginView all Krystal Biotech key metricsReturn to Krystal Biotech profile